Replies to post #1711 on Idenix Pharmaceuticals (IDIX)

[upndown1313]

I don't get your sarcasm. This is extremely important data to make decisions on and I highly appreciate Dew providing this as well as the other posters graphs and comparisons. The IMS data is very expensive and does give the average retail investor an "inside" advantage that you obviously don't appreciate. Instead of making a smart alec comment, you would be better off expressing your gratitude.